๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Impact of Sirolimus Duration on Hepatitis C Related Fibrosis Progression in Liver Transplant Recipients

โœ Scribed by M. Kim; M.P. Curry; C. C. Rogers

Book ID
114806344
Publisher
John Wiley and Sons
Year
2012
Tongue
English
Weight
455 KB
Volume
12
Category
Article
ISSN
1600-6135

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

One-year protocol liver biopsy can strat
One-year protocol liver biopsy can stratify fibrosis progression in liver transplant recipients with recurrent hepatitis C infection
โœ Roberto J. Firpi; Manal F. Abdelmalek; Consuelo Soldevila-Pico; Roniel Cabrera; ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 224 KB ๐Ÿ‘ 1 views

Determinants of progression to cirrhosis in hepatitis C virus (HCV) infection have been well described in the immunocompetent population but remain poorly defined in liver transplant (LT) recipients. This cohort study determines the factors contributing to the development of fibrosis and its rate of

Hepatitis C virus therapy in liver trans
Hepatitis C virus therapy in liver transplant recipients: Response predictors, effect on fibrosis progression, and importance of the initial stage of fibrosis
โœ Bruno Roche; Mylene Sebagh; Maria Laura Canfora; Teresa Antonini; Anne-Marie Roq ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 420 KB ๐Ÿ‘ 1 views

Antiviral therapy after liver transplantation (LT) using interferon (IFN) and ribavirin (RBV) can achieve a sustained virological response (SVR) rate ranging from 20% to 45%. The aims of our study were to assess efficacy and tolerability of therapy, effect on fibrosis progression and the importance